Board certified in internal medicine and medical oncology, Dr. Michael Postow is a physician known for advancing the treatment of melanoma through innovative immunotherapy research. Based at Memorial Sloan Kettering Cancer Center, Dr. Michael Postow leads clinical trials that develop immunotherapies for melanoma. He has been published over 200 times, and his research improves outcomes for patients with melanoma and other common cancers.
Dr. Postow teaches medical oncology and surgical oncology fellows at Memorial Sloan Kettering and is also an Associate Professor of Medicine at Weill Cornell Medical College. He has received several awards over the course of his career, including three Highly Cited Researcher Awards, 40 Under 40 in Cancer, and an Established Investigator Award by Melanoma Research Alliance.
Dr. Postow’s academic journey began at Duke University, where he earned a degree in biology with top honors. He next went to New York University School of Medicine, where he earned his MD and received multiple distinctions for scholarship and leadership. His postgraduate training included internship and residency in internal medicine at Brigham and Women’s Hospital/Harvard Medical School, followed by a fellowship in medical oncology at Memorial Sloan Kettering, where he was chief fellow.
Dr. Postow is a member of the American Society of Clinical Oncology. He is on the scientific advisory board of Melanoma Bridge Annual Meeting and the steering committee of the Melanoma Research Foundation Breakthrough Consortium. He enjoys mentoring young medical professionals.